[Selected biomarkers in the primary tumors of the central nervous system: short review].
Classification, grading and treatment of central nervous system tumors is currently based on morphology. Advances in molecular biology help to clarify pathogenesis, refine prognosis and detect potential targets for targeted therapy in a wide spectrum of CNS tumors. In this short review we present our view on selected diagnostic, prognostic and predictive biomarkers of primary CNS tumors, with an emphasis on application in daily praxis.
Oddelenie patologie UNLP Kosice, Trieda. svajdler@yahoo.com
B
B
Rychlý
P
P
Grossmann
A
A
Steňo
F
F
Pataky
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D001932:Brain Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D006801:Humans; D058990:Molecular Targeted Therapy; D057089:Pathology, Molecular
D014408:Biomarkers, Tumor